Daré Bioscience, Inc. (DARE) - Quarterly Income Statement

Home
DARE
Financials

3.23 (USD) • At close September 18, 2024

Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

	2024 Q2	2024 Q1	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4	2020 Q3	2020 Q2	2020 Q1	2019 Q4	2019 Q3	2019 Q2	2019 Q1	2018 Q4	2018 Q3	2018 Q2	2018 Q1	2017 Q4	2017 Q3	2017 Q2	2017 Q1	2016 Q4	2016 Q3	2016 Q2	2016 Q1	2015 Q4	2015 Q3	2015 Q2	2015 Q1	2014 Q4	2014 Q3	2014 Q2	2014 Q1	2013 Q4	2013 Q3	2013 Q2	2013 Q1
Revenue Numbers are in millions	0.022	0.009	1.808	1	0	0	10,000	0	10	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-1.834	0	0.642	1.192	0.766	0	0	0	0	0	0	0	0	0	0.033	0.047	0.006	0	0	0
Cost of Revenue Numbers are in millions	0.015	0.011	0.01	0.009	0.01	0.004	0.005	0.003	0.005	0.005	0.076	-0.018	0.007	0.006	0.025	0.025	0.021	0.013	0.125	0.133	0.163	0.113	0.275	0	0.25	0.1	0	0	0	0	0.15	0	0.25	0.25	0	0	0	0	0	0	0	0	0	0	0	0
Gross Profit Numbers are in millions	0.007	-0.001	1.798	0.991	-0.01	-0.004	9,999.995	-0.003	9.995	-0.005	-0.076	0.018	-0.007	-0.006	-0.025	-0.025	-0.021	-0.013	-0.125	-0.133	-0.163	-0.113	-0.275	0	-0.25	-0.1	-1.834	0	0.642	1.192	0.616	0	-0.25	-0.25	0	0	0	0	0	0	0.033	0.047	0.006	0	0	0
Gross Profit Ratio Numbers are in millions	0.312	-0.159	0.994	0.991	0	0	1	0	0.999	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	1	0.804	0	0	0	0	0	0	0	0	0	1	1	1	0	0	0
Reseach & Development Expenses Numbers are in millions	4.909	3.329	3.8	6.675	6.044	5.02	12.977	4.462	6.798	5.805	7.116	10.433	7.34	5.728	6.638	6.204	5.547	2.38	2.374	1.966	2.513	1.693	1.663	1.447	2.218	1.087	0.673	0.281	1.292	4.651	3.184	7.089	7.522	9.77	7.157	7.092	6.678	5.021	4.701	2.928	2.648	1.495	1.44	1.586	3.195	3.479
General & Administrative Expenses Numbers are in millions	2.473	2.703	3.08	2.697	2.946	3.362	3.154	2.677	2.818	2.595	2.427	2.236	1.823	1.965	1.802	1.378	1.578	1.874	1.487	1.452	1.47	1.39	1.295	1.175	1.407	1.403	2,704.853	1,052.628	3.375	3.587	10.355	2.374	2.773	3.118	11.224	2.954	2.717	2.681	8.587	2,441	2,029	1.51	0	1.227	1.392	1.972
Selling & Marketing Expenses Numbers are in millions	-0.015	-0.043	0.065	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-2,703.877	-1,051.575	0	0	-8.265	0	0	0	-8.352	0	0	0	-5.98	-2,438.559	-2,026.971	0	0	0	0	0
SG&A Numbers are in millions	2.433	2.66	3.145	2.697	2.946	3.362	3.154	2.677	2.818	2.595	2.427	2.236	1.823	1.965	1.802	1.378	1.578	1.874	1.487	1.452	1.47	1.39	1.295	1.175	1.407	1.403	0.976	1.053	3.375	3.587	2.09	2.374	2.773	3.118	2.872	2.954	2.717	2.681	2.607	2.441	2.029	1.51	1.575	1.227	1.392	1.972
Other Expenses Numbers are in millions	20.27	-0.733	0.114	0.025	0.227	0.34	0.1	0.119	0.03	0.002	0.001	0.002	0	0	-0.001	-0.001	0.002	0.002	-0.006	0.025	0.03	0.031	0.042	0.047	0.043	5,287.519	7,490.886	0	-0.13	-0.029	0	0	0.008	-0.007	0	0	0	-0.008	0	0	0	0	0	0	0	0
Operating Expenses Numbers are in millions	7.341	5.988	6.944	9.396	8.989	8.383	16.231	7.139	9.616	8.4	9.543	12.669	9.163	7.694	8.441	7.582	7.126	4.254	3.861	3.419	3.982	3.083	2.959	2.622	3.625	2.49	1.648	1.333	4.667	8.238	5.274	9.463	10.295	12.888	10.029	10.046	9.395	7.702	7.308	5.369	4.677	3.005	3.015	2.813	4.587	5.451
Operating Income Numbers are in millions	-7.334	-5.99	-5.146	-8.396	-8.989	-8.383	-16.231	-7.139	0.384	-8.4	-9.543	-12.669	-9.163	-7.694	-8.441	-7.582	-7.126	-4.254	-3.861	-3.419	-3.982	-3.083	-2.959	-2.622	-3.625	-7.677	-9.139	-1.333	-4.025	-5.546	-4.508	-9.463	-10.295	-12.888	-10.029	-10.046	-9.395	-7.702	-7.308	-5.369	-4.644	-2.958	-3.009	-2.813	-4.587	-5.451
Operating Income Ratio Numbers are in millions	-326.877	-643.926	-2.847	-8.396	0	0	-0.002	0	0.038	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4.983	0	-6.269	-4.653	-5.885	0	0	0	0	0	0	0	0	0	-140.727	-62.936	-501.5	0	0	0
Total Other Income Expenses Net Numbers are in millions	20.245	-0.766	0.089	0.097	0.227	0.34	0.287	0.119	0.03	0.002	0.001	0.002	0	0.37	-0.001	-0.001	0.002	0.002	-0.006	0.025	0.03	0.031	0.042	0.047	0.043	-5.176	0.008	-0.296	-0.13	1.471	-0.001	-0.496	0.008	-0.007	-0.679	-0.505	-0.512	-0.008	-0.159	-0.189	-2.493	0.504	-0.042	-0.007	0.02	0.231
Income Before Tax Numbers are in millions	12.911	-6.755	-5.058	-8.299	-8.762	-8.043	-15.943	-7.02	0.414	-8.399	-9.542	-12.667	-9.163	-7.324	-8.441	-7.583	-7.124	-4.252	-3.866	-3.393	-3.952	-3.052	-2.917	-2.574	-3.582	-7.666	-9.131	-1.63	-4.135	-6.339	-4.945	-9.959	-10.859	-13.542	-10.708	-10.551	-9.907	-8.428	-7.467	-5.558	-7.403	-2.914	-3.48	-3.198	-4.893	-5.572
Income Before Tax Ratio Numbers are in millions	575.392	-726.226	-2.798	-8.299	0	0	-0.002	0	0.041	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4.979	0	-6.441	-5.318	-6.456	0	0	0	0	0	0	0	0	0	-224.333	-62	-580	0	0	0
Income Tax Expense Numbers are in millions	0	0	-0.034	-0.009	-0.112	-0.34	-437.631	-0.119	-0.03	-0.002	-0.069	0.024	0	-0.37	0	0	0	0	0	0	0	0	0	0	-0	-5.188	0.08	-1.333	0	0.797	0.456	0.025	0.597	0.663	0.002	0.004	0.001	0.721	0.004	0.002	0.268	0.461	0.43	0.378	0.326	0.353
Net Income Numbers are in millions	12.911	-6.755	-5.058	-8.299	-8.762	-8.043	-15.943	-6.901	0.414	-8.397	-9.542	-12.667	-9.163	-7.324	-8.441	-7.583	-7.124	-4.252	-3.866	-3.393	-3.952	-3.052	-2.917	-2.574	-3.582	-7.666	-9.131	-1.63	-4.135	-6.339	-4.945	-9.959	-10.859	-13.542	-10.708	-10.551	-9.907	-8.428	-7.467	-5.558	-7.403	-2.914	-3.48	-3.198	-4.893	-5.572
Net Income Ratio Numbers are in millions	575.392	-726.226	-2.798	-8.299	0	0	-0.002	0	0.041	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4.979	0	-6.441	-5.318	-6.456	0	0	0	0	0	0	0	0	0	-224.333	-62	-580	0	0	0
EPS Numbers are in millions	1.53	-0.81	-0.69	-1.09	-1.22	-1.13	-2.34	-0.98	0.005	-0.1	-0.13	-0.18	-0.18	-0.16	-0.27	-0.24	-0.27	-0.18	-0.16	-0.2	-0.25	-0.27	-0.26	-0.23	-0.31	-0.88	-1.05	-0.33	-4.54	-6.97	-1.71	-12.15	-3.97	-4.95	-3.91	-3.86	-3.71	-4.14	-3.67	-2.76	-4.38	-1.53	-47.87	-43.99	-79.6	-90.92
EPS Diluted Numbers are in millions	1.52	-0.81	-0.69	-1.09	-1.22	-1.13	-2.34	-0.98	0.005	-0.1	-0.13	-0.18	-0.18	-0.16	-0.27	-0.24	-0.27	-0.18	-0.16	-0.2	-0.25	-0.27	-0.26	-0.23	-0.31	-0.88	-1.05	-0.33	-4.54	-6.97	-1.7	-11.99	-3.97	-4.95	-3.91	-3.86	-3.71	-4.14	-3.67	-2.76	-4.38	-1.53	-47.87	-43.99	-79.6	-90.92
EBITDA Numbers are in millions	-7.319	-5.979	-5.136	-8.396	-8.98	-8.383	-16.231	-7.136	0.39	-8.395	-9.536	-12.663	-9.156	-8.057	-8.434	-7.569	-7.114	-4.242	-3.853	-3.417	-3.981	-3.082	-2.957	-2.621	-3.625	2.686	-9.139	-1.333	-3.991	-6.947	-4.422	-9.37	-10.204	-12.811	-9.964	-9.996	-9.352	-7.658	-7.271	-5.337	-4.615	-2.921	-2.974	-2.771	-4.537	-5.379
EBITDA Ratio Numbers are in millions	-326.189	-642.767	-2.841	-8.396	0	0	-0.002	0	0.039	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4.983	0	-6.217	-5.828	-5.773	0	0	0	0	0	0	0	0	0	-139.848	-62.149	-495.667	0	0	0

Daré Bioscience, Inc.

NASDAQ:DARE Add to watchlist

NASDAQ:DARE